Source: Eur Respir J 2009; 34: 1031-1039
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Menchini L., Remy-Jardin M., Faivre J-B., Copin M-C., Ramon P., Matran R., Deken V., Duhamel A., Remy J.. Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients. Eur Respir J 2009; 34: 1031-1039

Member's Comments

No comment yet.

Related content which might interest you: Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Source: Eur Respir J 2002; 19: 632-638 Year: 2002 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Creatinine-height index, pulmonary function and dyspnoa in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 450-454 Year: 2003 Pulmonary hypertension in COPD: results from the ASPIRE registry Source: Eur Respir J 2013; 41: 1292-1301 Year: 2013 Venous thromboemboli and exacerbations of COPD Source: Eur Respir J 2010; 35: 1243-1248 Year: 2010 Mild chronic obstructive pulmonary disease in smokers over the age of 30 Source: International Congress 2019 – Challenges in tobacco control and cessation Year: 2019 Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Chronic obstructive pulmonary disease in smokers with asthma Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011 Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Chronic obstructive pulmonary disease and pulmonary embolism Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 Prognostic impact of chronic obstructive pulmonary disease in severe symptomatic aortic stenosis Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016